Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

BLU Insider Trading (BELLUS Health)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$118,989.56

BELLUS Health Insider Trading History Chart

This chart shows the insider buying and selling history at BELLUS Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BELLUS Health Share Price & Price History

Current Price: C$15.11
Price Change: Price Increase of +0.58 (3.99%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for BLU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

BELLUS Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2022Francois DesjardinsSenior OfficerSell14,053C$8.47C$118,989.5681,722
10/20/2020Roberto BelliniDirectorBuy42,500C$3.05C$129,591.00630,062
7/13/2020Pierre LarochelleDirectorBuy55,000C$3.75C$206,250.00131,389
7/6/2020Francesco BelliniDirectorBuy50,000C$3.82C$191,058.00397,479
6/10/2020Orbimed Advisors LLC InsiderSell36,400C$14.08C$512,657.601,182,416
See Full Table
Average 126% gains – NO losers!?  
An epic crash is all but inevitable, but these dark times can offer staggering opportunities.

Today, Dr. Martin Weiss reveals "Crash Profit Trades" that could have produced average gains of 126% even when stocks tumbled.

All with NO losing trades!

Click Here to Discover the Secret.

SEC Filings (Institutional Ownership Changes) for BELLUS Health (TSE:BLU)

BELLUS Health logo
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.
Read More on BELLUS Health

Today's Range

Now: C$15.11
Low: C$14.61
High: C$15.35

50 Day Range

MA: C$12.18
Low: C$9.95
High: C$15.45

52 Week Range

Now: C$15.11
Low: C$3.79
High: C$16.24


115,950 shs

Average Volume

126,265 shs

Market Capitalization

C$1.90 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BELLUS Health?

BELLUS Health's top insider shareholders include:
  1. Roberto Bellini (Director)
  2. Francois Desjardins (Senior Officer)
Learn More about top insider investors at BELLUS Health.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.